Author(s):
Praful Sahare, Amit Nayak, Alok Pal Jain, Harikishor Barange
Email(s):
praphul.222@gmail.com
DOI:
10.5958/2231-5675.2021.00006.5 
Address:
Praful Sahare*, Dr. Amit Nayak, Dr. Alok Pal Jain, Harikishor Barange
RKDF College of Pharmacy, SRK University, Bhopal- 462026 Madhya Pradesh, India.
*Corresponding Author
Published In:
Volume - 11,
Issue - 1,
Year - 2021
ABSTRACT:
A simple, accurate rapid and precise has been developed and validated for estimation of Canagliflozin hemihydrate in Pharmaceutical Tablet Formulation by VU-Spectrophotometer and RP-HPLC Method. The successful estimation was carried out of the drug product is developed on the Jasco V-630 and Shimadzu-UV-1700 for VU-Spectrophotometer method and for HPLC successful estimation was carried out of the drug product is developed on the ACE Column C18 (150mm x 4.6mm, 5µm or equivalent) at ambient temperature using Acetonitrile: Orthophosphoric acid (1%) (60: 40 v/v) as mobile phase composition. The flow rate was adjusted to 1.0mL/minute and the absorption maxima were observed on UV detector at 290nm. Retention time for Canagliflozin hemihyd rate 3.0±0.5 min. The linearity was obtained in the concentration range of 80%-120% for Canagliflozin hemihydrate. For the HPLC method injection volume should be 20µL.The method was robust with respect to change in flow rate, temperature and composition of mobile phase. The method was validated statistically and applied successfully for the determination of Canagliflozin hemihydrate by VU-Spectrophotometer and RP-HPLC method. Validation studies revealed that method is specific, rapid, reliable, and reproducible. The high recovery and low relative standard deviation confirm the suitability of the method for the routine determination of Canagliflozin hemihydratein pharmaceutical cream formulation.
Cite this article:
Praful Sahare, Amit Nayak, Alok Pal Jain, Harikishor Barange. Development of Validated Analytical Methods and Stability Indicating studies for Pharmaceutical Formulation. Asian J. Pharm. Ana. 2021; 11(1):29-37. doi: 10.5958/2231-5675.2021.00006.5
Cite(Electronic):
Praful Sahare, Amit Nayak, Alok Pal Jain, Harikishor Barange. Development of Validated Analytical Methods and Stability Indicating studies for Pharmaceutical Formulation. Asian J. Pharm. Ana. 2021; 11(1):29-37. doi: 10.5958/2231-5675.2021.00006.5 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2021-11-1-6
REFERENCE:
1. Sena Caglar and Ali Rahmi Alp, A Validated High Performance Liquid Chromatography Method for the Determination of Saxagliptin and Metformin in Bulk, a Stability Indicating Study, J Anal Bioanal Tech, 2014: p. 1-5
2. Panighahy U.P. and Reddy S.K., A Novel Validated RP-HPLC-DAD Method for the Simultaneous Estimation of Metformin Hydrochloride and Canagliflozin in Bulk and Pharmaceutical Tablet Dosage Form with Forced Degradation Studies, Oriental Journal of Chemistry, 31(3), 2015: p. 1489-1507
3. http://www.drugbank.ca/drug/DB08907
4. https://en.wikipedia.org/wiki/Canagliflozin
5. www.news-medical.net/drug/Invokana.aspx
6. Nomura S., Sakamaki S. and Hangu M., Discovery of Canagliflozin, A Novel C-glucose with thiopene ring, as Sodium-Dependent Glucose co-transporter 2- Inhibitor for the Treatment of Type 2 Diabetes Mellitus, J. Med Chem, 53(17), 2010: p. 6355-6360
7. Dai XM, An N, Wu JM, Li HY and Zhang QM, Development and Validation of HPLC-UV-MS method for the Control of Four Anti-diabetic Drugs in Suspected Counterfeit Products, 45(3), 2010: p.347-352
8. Reddy N.P. and Chevela N.T., RP-HPLC Method Development and Validation for the Simultaneous Estimation of Metformin and Canagliflozin in Tablet Dosage Form, International Journal of Pharma Sciences, 5(4), 2015: p. 1155-1159
9. Kaur S., Wakode S. and Singh H., Development and Validation of UV Spectroscopic Method for Determination of Canagliflozin in Bulk and Pharmaceutical Dosage Form, Pharmaceutical Methods, 6(2), 2015: p. 82-86
10. Suneetha A. and Sharmila D., A Validated Stability Indicating RP-HPLC Method for Estimation of Canagliflozin in Dosage Form, Research Journal of Pharmaceutical, Biological and Chemical Sciences, 6(5), 2015, p. 1186-1194
11. Gandhimathi R., Vijayaraj S. and Jyothirmaie M.P., Analytical Process of Drug by Ultraviolet (UV) Spectroscopy: a review, International Journal of Pharmaceutical Research and Analysis, 2(2), 2012, p.72-78
12. Kalra K., Method Development and Validation of Analytical Procedure, Quality Control of Herbal Medicines and Related Areas, InTech Europe, Shanghai: 953-307, 2011, p.1-16
13. Kealey D, Haines P.J., Instant notes Analytical Chemistry, 1st Edition, Bios Scientific Publisher Limited, New Dehli: 2002; p.218-223
14. Frank A.S., Handbook of Instrumental Techniques for Analytical Chemistry, National Science Foundation, Arlington, Virginia: 1997: p.15-25
15. www.chemguide.co.uk/analysis/uvvisible/spectrometer:22April2016,12:40
16. Kealey D., and Haines P.J., Instant Notes Analytical Chemistry, 1st Edition, Bios Scientific Publisher Limited, New Dehli, 2002, p.218-223
17. Sethi P.D. and Sethi R., HPLC-Quantitative Analysis of Pharmaceutical Formulation, Vol 2, 1st Edition, CBS Publishers and Distributors, New Dehli, 2007, p.443
18. Verzel M. and Dewaele C., Preparative High Performance Liquid Chromatography: A Practical Guideline, 1st Edition, TEC Gent, Belgium: 1986, p.44-48
19. Beckett A.H., and Stenlake J.B., Practical Pharmaceutical Chemistry, Part-II, 4th Edition, CBS Publishers and Distributors, New Dehli, 2004, p.281-300
20. ICH, Validation of Analytical Procedures: Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guideline, 1994, p.630
21. Kulkarni G.T., Gowthamrajan K., Suresh B., “Stability Testing of Pharmaceutical Products: An Over View” Indian J. Pharma. Educ., 2004, 38(4), 194-198.
22. Ahuja S. and Dong M.W., “Handbook of Pharmaceutical Analysis by HPLC Separation Science and Technology”, 1st Edition, Academic press, (6): 336-337
23. Mazzo D.J., “International Stability Testing”, Interpharm Press, Inc., USA, 1999: p.11-18
24. Acharya M.M, “Pharmaceutical Stability Testing and Studies, An overview”, The Eastern Pharmacist, 1999: p.31-36
25. Klick S., Muijselaar P., Waterval J, Eichinger T., Korn C., Gerding T. K., “Towords a Generic Apporach for Stress Testing of Drug Substance and Drug Products”, Pharmaceutical Technology, 2005 (2): p.48-66
26. Reynolds D.W., Frcchine K.L., Mullaney J.F., Alsante K.M., Hatajik T. D., and Motto M. G., “Available Guidance and Best Practices for Conducing Forced Degradation Studies”, Pharm. Tech. 2002, 26(2): 48-54
27. Singh S.S., and Bakshi M., “Development of Validated Stability Indicating Assay Method, Critical Review”, J. Pharm. Biom. Anal., 2002, (28): 1011-1040
28. FDA, “International Conference on Harmonization: Stability Testing of New Drug Substance and Product”, Federal Register (ICH Q1A), 1994, 59(183): p.48753-48759
29. FDA, “International Conference on Harmonization: Draft Revised Guidance on Q1A(R) Stability Testing of New Drug Substance and Product”, Federal Register [ICHQ1A(R)], 2000, 65(78): p.21446-21453
30. Carstensen J.T., and Rhodes C.T., “Drug and Pharmaceutical Science, Drug Stability Principal and Practices”, Journal of applied Pharmaceutical Science, Lalra, Vol-107: p.331
31. Singh S.S., and Bakshi M., “Guidance on Conduct of Stress Tests to Determine Inherent Stability of Drug”, Pharm. Tech., 2000, 4; p.01-14
32. ICH, International Conference on Harmonization: Stability testing of New Drug substance and Product, Q1A (R2), 2003: Geneva.